Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 308.2 | 161.1 | 78.1 |
| Revenue growth | 91.3% | 106.3% | |
| Cost of goods sold | 39.0 | 22.5 | 12.0 |
| Gross profit | 269.1 | 138.6 | 66.1 |
| Gross margin | 87.3% | 86.0% | 84.7% |
| Sales and marketing | 268.1 | 191.4 | 118.5 |
| Research and development | 73.7 | 43.5 | 24.6 |
| General and administrative | 53.5 | 54.3 | 15.5 |
| EBIT | -126.1 | -150.5 | -92.5 |
| EBIT margin | -40.9% | -93.4% | -118.5% |
| Pre-tax income | -127.0 | -150.0 | -90.9 |
| Income taxes | 2.3 | 2.2 | 0.7 |
| Net income | -129.3 | -152.2 | -91.6 |
| Net margin | -42.0% | -94.5% | -117.3% |
| |
| Diluted EPS | ($4.26) | ($12.63) | ($8.07) |
| Shares outstanding (diluted) | 30.3 | 12.0 | 11.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|